Genetic manipulation of the MAPK pathway, one of the neurotrophin signaling pathways, has received much attention, which postulated that the dysfunction of this pathway played a key role in the pathophysiology of mood disorders [37], especially in depression-like behavior [38]. This evidence concerns the gene BDNF and depressive symptom measurement.